Experienced in Hemolytic-Uremic Syndrome

Ross I. Baker

Monash Avenue, 
Perth, WA, AU 
Experienced in Hemolytic-Uremic Syndrome
Monash Avenue, 
Perth, WA, AU 
OverviewLocationsClinical Research

Overview

Ross Baker practices in Perth, Australia. Mr. Baker is rated as an Experienced expert by MediFind in the treatment of Hemolytic-Uremic Syndrome. His top areas of expertise are Von Willebrand Disease (VWD), Blood Clots, Purpura, and Thrombocytopenia.

His clinical research consists of co-authoring 85 peer reviewed articles and participating in 2 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 2 articles in the study of Hemolytic-Uremic Syndrome.

Gender
Male

Locations

Monash Avenue, Perth, WA 6009, Australia

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

A Phase 3 Open Label Extension Study of Fostamatinib Disodium in the Treatment of Persistent/Chronic Immune Thrombocytopenic Purpura
A Phase 3 Open Label Extension Study of Fostamatinib Disodium in the Treatment of Persistent/Chronic Immune Thrombocytopenic Purpura
Enrollment Status: Completed
Publish Date: December 11, 2023
Intervention Type: Drug
Study Drug: Fostamatinib
Study Phase: Phase 3
A Phase 3, Randomized, Double-blind, Placebo-controlled Study to Assess the Efficacy and Safety of Sutimlimab in Patients With Primary Cold Agglutinin Disease Without a Recent History of Blood Transfusion
A Phase 3, Randomized, Double-blind, Placebo-controlled Study to Assess the Efficacy and Safety of Sutimlimab in Patients With Primary Cold Agglutinin Disease Without a Recent History of Blood Transfusion
Enrollment Status: Completed
Publish Date: December 23, 2022
Intervention Type: Drug
Study Drug: Sutimlimab
Study Phase: Phase 3
View 1 Less Clinical Trial

85 Total Publications

International opinion survey on nomenclature for platelet-type von Willebrand disease: communication from the SSC of the ISTH.
International opinion survey on nomenclature for platelet-type von Willebrand disease: communication from the SSC of the ISTH.
Journal: Journal of thrombosis and haemostasis : JTH
Published: January 07, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Baker's expertise for a condition
ConditionClose
    View All 21 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile